Cell culture studies of the efficacy and barrier to resistance of sofosbuvir/velpatasvir and glecaprevir/pibrentasvir against hepatitis C virus genotypes 2a, 2b and 2c

    Carlota Fernandez-Antunez
    Carlota Fernandez-Antunez
    Lotte S Mikkelsen
    Lotte S Mikkelsen
    Jannie Pedersen
    Jannie Pedersen

    Antimicrobial agents and chemotherapy, 2019.

    Cited by: 0|Bibtex|Views1|Links
    WOS

    Abstract:

    Introduction of highly efficient therapies with direct-acting antivirals (DAA) for patients with chronic hepatitis C virus (HCV) infection offers exceptional opportunities to globally control this deadly disease. For achieving this ambitious goal, it is essential to prevent antiviral resistance against the most optimal first-line and retr...More

    Code:

    Data:

    Your rating :
    0

     

    Tags
    Comments